Researchers in many peer-reviewed journals have had to declare their conflicts of interest for several years now. It will be good to see physicians do the same sort of things.<\/p>\nThe Cleveland Clinic is to be commended for this. More openness in pharma\/doctor relationships should be useful, eventually.<\/p>\n
I expect there may be a a tricky transition period when real education efforts need to take place. Not many doctors can remain ‘clean’ when it comes to drug companies. One example would be free samples. Doctors get these all the time and they have been really useful because we have been able to determine if a type of medication has side effects without having to get an entire prescription.<\/p>\n
Often the binders used by different drug companies result in odd skin rashes, etc. So we have used the free samples to narrow down to ones that actually work. Is it a conflict of interest for a doctor to use free samples from a drug company he has a relationship with?<\/p>\n
My answer would be no but I would like to know what the relationship was and talk to him about it. Most doctors are not going to go too far down the primrose path with a drug company because there are dangers aplenty. <\/p>\n
and details of these interactions would eventually also serve as a check on those doctors who might be tempted to take a long journey down the path.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"
by bobster1985 Clinic to Reveal All Doctor-Drug Industry Ties on the Web: [Via Discover Magazine | RSS] Doctors and drug company money have gone together like peas and carrots … [More] Researchers in many peer-reviewed journals have had to declare their conflicts of interest for several years now. It will be good to see physicians … Continue reading Openness for doctors<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","footnotes":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false},"categories":[1,4],"tags":[],"class_list":["post-455","post","type-post","status-publish","format-standard","hentry","category-general","category-web-20"],"jetpack_featured_media_url":"","jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pe2yp-7l","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":282,"url":"https:\/\/www.spreadingscience.com\/2008\/07\/15\/medicine-20\/","url_meta":{"origin":455,"position":0},"title":"Medicine 2.0","date":"July 15, 2008","format":false,"excerpt":"by D'Arcy Norman Why Health or Medicine 2.0? [ScienceRoll]: [Via The DNA Network] While medicine is usually at the forefront of new technology for diagnosis and treatment, the patient-doctor interface has not followed. Perhaps that might change soon.Some interesting statistics have recently been published. According to Pharma 2.0: 99% of\u2026","rel":"","context":"In "Science"","img":{"alt_text":"","src":"https:\/\/i1.wp.com\/www.spreadingscience.com\/wp-content\/uploads\/2008\/07\/xray.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":192,"url":"https:\/\/www.spreadingscience.com\/2008\/05\/21\/open-and-transparent\/","url_meta":{"origin":455,"position":1},"title":"Open and transparent","date":"May 21, 2008","format":false,"excerpt":"by Shutr Doctors Say \u2018I\u2019m Sorry\u2019 Before \u2018See You in Court\u2019 : [Via New York Times] In 40 years as a highly regarded cancer surgeon, Dr. Tapas K. Das Gupta had never made a mistake like this. As with any doctor, there had been occasional errors in diagnosis or judgment.\u2026","rel":"","context":"In "General"","img":{"alt_text":"","src":"https:\/\/i1.wp.com\/www.spreadingscience.com\/wp-content\/uploads\/2008\/05\/hands.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":467,"url":"https:\/\/www.spreadingscience.com\/2008\/12\/15\/pools-for-drugs\/","url_meta":{"origin":455,"position":2},"title":"Pools for drugs","date":"December 15, 2008","format":false,"excerpt":"by seanmcgrath Goldman\u2019s pool for drug research: [Via business|bytes|genes|molecules] And while we are on the subject of blog posts by Derek Lowe, here's one where he points to news about Goldman Sachs funding a large pharma company and using a \"new\" business model(The model involves) a different approach, creating a\u2026","rel":"","context":"In "Science"","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.spreadingscience.com\/wp-content\/uploads\/2008\/12\/pool.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":587,"url":"https:\/\/www.spreadingscience.com\/2009\/09\/25\/turning-medicine-on-its-head\/","url_meta":{"origin":455,"position":3},"title":"Turning medicine on its head","date":"September 25, 2009","format":false,"excerpt":"by psyberartist It's Time to Turn to Research's Most Valuable, Yet Underutilized Resource: Patients: [Via FasterCures] By Margaret Anderson, COO, FasterCures A piece in yesterday's New York Times, Research Trove: Patients' Online Data, recounts the story of a young woman stricken by a rare pulmonary disease, and her attempts to\u2026","rel":"","context":"In "Science"","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.spreadingscience.com\/wp-content\/uploads\/2009\/09\/reverese.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":597,"url":"https:\/\/www.spreadingscience.com\/2009\/10\/29\/a-very-big-challenge-for-biopharma\/","url_meta":{"origin":455,"position":4},"title":"A very big challenge for biopharma","date":"October 29, 2009","format":false,"excerpt":"Loose coupling and biopharma: [Via business|bytes|genes|molecules] A few days ago, via the typical following of links that is typical of a good search and browse section on the interwebs, I chanced upon a discussion about a presentation given by Justin Gehtland at RailsConf. The talk was entitled Small Things, Loosely\u2026","rel":"","context":"In "Open Access"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":505,"url":"https:\/\/www.spreadingscience.com\/2009\/03\/18\/high-tech-helping-biotech-innovate\/","url_meta":{"origin":455,"position":5},"title":"High tech helping biotech innovate","date":"March 18, 2009","format":false,"excerpt":"by \"T\" altered art Innovation, biotech, software, etc: [Via business|bytes|genes|molecules] There are a lot of synergistic effects of high tech on biotech. Much of the work done today requires high powered instruments running very complex algorithms. But it still requires highly skilled people to do the work. In a talk\u2026","rel":"","context":"In "Knowledge Creation"","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/posts\/455"}],"collection":[{"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/comments?post=455"}],"version-history":[{"count":0,"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/posts\/455\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/media?parent=455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/categories?post=455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.spreadingscience.com\/wp-json\/wp\/v2\/tags?post=455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}